Compare TITN & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TITN | RGNX |
|---|---|---|
| Founded | 1980 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 443.9M | 528.6M |
| IPO Year | 2007 | 2015 |
| Metric | TITN | RGNX |
|---|---|---|
| Price | $19.98 | $9.73 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $19.00 | ★ $28.75 |
| AVG Volume (30 Days) | 147.5K | ★ 2.5M |
| Earning Date | 05-21-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.08 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,427,107,000.00 | $10,393,000.00 |
| Revenue This Year | N/A | $51.21 |
| Revenue Next Year | $3.75 | $19.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 126.48 |
| 52 Week Low | $13.21 | $5.46 |
| 52 Week High | $25.00 | $16.19 |
| Indicator | TITN | RGNX |
|---|---|---|
| Relative Strength Index (RSI) | 53.06 | 41.84 |
| Support Level | $18.72 | $9.51 |
| Resistance Level | $20.21 | $10.16 |
| Average True Range (ATR) | 0.73 | 1.04 |
| MACD | 0.15 | -0.56 |
| Stochastic Oscillator | 91.68 | 17.69 |
Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.